-
December 1, 2016 Lupin and Eli Lilly Expand Partnership in India
-
November 29, 2016 Lupin Receives FDA Approval for Generic Nuvigil® Tablets
-
November 23, 2016 Lupin Receives Tentative Approval for Generic Epzicom® Tablets
-
November 17, 2016 Lupin Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets
-
November 15, 2016 Lupin Launches Generic Activella® Tablets in the US
-
November 11, 2016 Lupin Launches Novel Injectable Iron Formulation Under Brand Names “ISOFER” and “JILAZO” in India
-
November 9, 2016 Lupin’s Quarter II, FY2017 – Results
-
November 4, 2016 Lupin receives EIR from US FDA for Goa, March 2016 Inspection
-
November 1, 2016 Lupin Receives FDA Approval for Generic Ortho-Cyclen® 28 Tablets
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications